2019
DOI: 10.1007/s00428-019-02658-x
|View full text |Cite
|
Sign up to set email alerts
|

Lineage-negative lymphoma with a helper innate lymphoid cell phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 38 publications
0
8
0
Order By: Relevance
“…Immune cell infiltration was closely as0sociated with the development of breast cancer. Given that the PPPCs family was associated with immune system diseases [ 19 ] and immune system tumors [ 20 ], we analyzed whether these factors affected the immune cell infiltration of breast cancer tissues. Among the highly expressed genes in breast cancer tissues, PPP1CA was negatively correlated with CD8 + T cell and macrophage infiltration, while PPP2CA was positively correlated with infiltration.…”
Section: Resultsmentioning
confidence: 99%
“…Immune cell infiltration was closely as0sociated with the development of breast cancer. Given that the PPPCs family was associated with immune system diseases [ 19 ] and immune system tumors [ 20 ], we analyzed whether these factors affected the immune cell infiltration of breast cancer tissues. Among the highly expressed genes in breast cancer tissues, PPP1CA was negatively correlated with CD8 + T cell and macrophage infiltration, while PPP2CA was positively correlated with infiltration.…”
Section: Resultsmentioning
confidence: 99%
“…IGLL5 located within the immunoglobulin lambda locus encoded one of the IGLLs, which were the immunoglobulin lambda joining 1 and the immunoglobulin lambda constant 1 gene segments. Only a limited number of research has shown that IGLL5 has a frequent mutation in chronic lymphocytic leukemia [33,34], lymphoma [35][36][37], and multiple myeloma [38,39]; besides, IGLL5 has a prognostic value in several diseases, such as multiple myeloma and glioblastoma [39][40][41]. Moreover, previous studies have shown that IGLL5 has a prognostic value in ccRCC, while no in-depth study has concentrated on TICs.…”
Section: Discussionmentioning
confidence: 99%
“…Previous research on IGLL5 and IL2RA focused predominantly on hematological malignancies. Fusion or mutation of IGLL5 was identified in Burkitt lymphoma, multiple lymphadenopathy, diffuse large B cell lymphoma, multiple myeloma, and chronic lymphocytic leukemia ( Kasar et al, 2015 ; White et al, 2018 ; Panea et al, 2019 ; Li et al, 2020 ; Mosquera Orgueira et al, 2021 ). It has been reported that IGLL5 may act as a risk factor and was related with metastasis and poor prognosis of multiple myeloma ( White et al, 2018 ; Barwick et al, 2019 ; D'Agostino et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%